{"id":40018,"date":"2025-06-10T13:01:44","date_gmt":"2025-06-10T04:01:44","guid":{"rendered":"https:\/\/www.microsoft.com\/ja-jp\/industry\/blog\/?p=40018"},"modified":"2025-06-19T15:58:10","modified_gmt":"2025-06-19T06:58:10","slug":"ai_ml_in_drug_discovery","status":"publish","type":"post","link":"https:\/\/www.microsoft.com\/ja-jp\/industry\/blog\/health\/2025\/06\/10\/ai_ml_in_drug_discovery\/","title":{"rendered":"\u5275\u85ac\u306b\u304a\u3051\u308b AI\/ML \u306e\u6d3b\u7528\u3068 Microsoft \u306e\u53d6\u308a\u7d44\u307f"},"content":{"rendered":"\n
\u4e00\u822c\u306b\u3001\u65b0\u85ac\u306e\u5275\u51fa\u306b\u306f\u81a8\u5927\u306a\u6642\u9593\u3068\u30b3\u30b9\u30c8\u304c\u304b\u304b\u308b\u4e00\u65b9\u3001\u305d\u306e\u6210\u529f\u78ba\u7387\u306f\u6975\u3081\u3066\u4f4e\u3044\u3068\u3044\u308f\u308c\u3066\u3044\u307e\u3059\u30022012~22 \u5e74\u306e 11 \u5e74\u9593\u306b\u304a\u3051\u308b\u65e5\u672c\u306e\u88fd\u85ac\u4f01\u696d\u306e\u7814\u7a76\u958b\u767a\u306b\u5bfe\u3059\u308b\u533b\u85ac\u7523\u696d\u653f\u7b56\u7814\u7a76\u6240\u306e\u8abf\u67fb[1]<\/a><\/sup>\u306b\u3088\u308b\u3068\u30011 \u65b0\u85ac\u3092\u30b0\u30ed\u30fc\u30d0\u30eb\u958b\u767a\u3067\u4e0a\u5e02\u3055\u305b\u308b\u307e\u3067\u3001\u57fa\u790e\u7814\u7a76\u304b\u3089\u7533\u8acb\u307e\u3067\u306e\u5168\u671f\u9593\u306b\u8981\u3059\u308b\u7814\u7a76\u958b\u767a\u8cbb\u306f\u7d04 131 \u5104\u5186\u3001\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u6210\u529f\u78ba\u7387\u306f 3.4%\uff08\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u6570\u3067\u306f\u306a\u304f\u5408\u6210\u5316\u5408\u7269\u6570\u30d9\u30fc\u30b9\u306e\u5834\u5408\u306f\u4e00\u822c\u306b 1\/25,000 \u3068\u3082\u3044\u308f\u308c\u307e\u3059\uff09\u3001\u305d\u3057\u3066\u6240\u7528\u671f\u9593\u306f 14 \u5e74 4 \u304b\u6708\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u8abf\u67fb\u306e\u5bfe\u8c61\u3084\u63a8\u8a08\u306e\u65b9\u5f0f\u306b\u3088\u308b\u6570\u5024\u306e\u632f\u308c\u5e45\u306f\u3042\u308b\u3082\u306e\u306e\u3001\u3053\u3046\u3057\u305f\u30b3\u30b9\u30c8\u3084\u6210\u529f\u78ba\u7387\u3001\u671f\u9593\u306b\u4fc2\u308b\u50be\u5411\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u3082\u540c\u69d8[2]<\/a><\/sup>\u3067\u3042\u308a\u3001\u6628\u4eca\u306e\u30a2\u30f3\u30e1\u30c3\u30c8\u30e1\u30c7\u30a3\u30ab\u30eb\u30cb\u30fc\u30ba\u306e\u8907\u96d1\u5316\u3084\u3001\u7279\u306b\u4f4e\u5206\u5b50\u9818\u57df\u306b\u304a\u3051\u308b\u5275\u85ac\u30bf\u30fc\u30b2\u30c3\u30c8\u306e\u67af\u6e07\u306a\u3069\u306b\u3088\u308a\u3001\u65b0\u85ac\u5275\u51fa\u306e\u96e3\u5ea6\u306f\u307e\u3059\u307e\u3059\u9ad8\u307e\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n <\/p>\n\n\n\n \u3053\u3046\u3057\u305f\u30d3\u30b8\u30cd\u30b9\u74b0\u5883\u4e0b\u3067\u88fd\u85ac\u4f01\u696d\u5404\u793e\u306f\u3001\u5168\u793e\u30fb\u4e8b\u696d\u6226\u7565\u30ec\u30d9\u30eb\u3067\u306f\u6ce8\u529b\u9818\u57df\u306e\u9078\u629e\u3084 M&A\u3001\u30aa\u30fc\u30d7\u30f3\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u52a0\u901f\u7b49\u306e\u69d8\u3005\u306a\u65bd\u7b56\u3092\u8b1b\u3058\u3064\u3064\u65b0\u85ac\u5275\u51fa\u30d7\u30ed\u30bb\u30b9\u305d\u306e\u3082\u306e\u306e\u751f\u7523\u6027\u5411\u4e0a\u306b\u3082\u52aa\u3081\u3089\u308c\u3066\u304a\u308a\u3001AI\/ML \u306e\u6d3b\u7528\u306f\u305d\u306e\u65b9\u7b56\u306e\u4e00\u3064\u3068\u3057\u3066\u9ad8\u3044\u671f\u5f85\u3092\u6301\u305f\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070 McKinsey & Company \u793e\u306e\u8a66\u7b97\u3067\u306f\u3001AI\/ML \u306e\u6d3b\u7528\u306b\u3088\u308a\u88fd\u85ac\u4f01\u696d\u306f\u5275\u85ac\u30b3\u30b9\u30c8\u3092 30\u301c50 \uff05\u524a\u6e1b\u3057\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u30b9\u30d4\u30fc\u30c9\u3092 20 \uff05\u4ee5\u4e0a\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3068\u3055\u308c\u3066\u3044\u307e\u3059[<\/sup><\/a>3<\/a><\/sup>]<\/sup><\/a>\u3002<\/p>\n\n\n\n \u306a\u304a\u3001AI\/ML \u306e\u6d3b\u7528\u306f\u65b0\u85ac\u5275\u51fa\u30d7\u30ed\u30bb\u30b9\u306e\u5168\u30b9\u30c6\u30fc\u30b8\uff08\u6a19\u7684\u540c\u5b9a~\u5e02\u8ca9\u5f8c\u8abf\u67fb\uff09\u306b\u304a\u3044\u3066\u591a\u5c90\u306b\u308f\u305f\u308b\u30b7\u30ca\u30ea\u30aa\u304c\u8003\u3048\u3089\u308c\u307e\u3059\u304c[4]<\/a><\/sup>\u3001\u672c\u7a3f\u3067\u306f R&D \u9818\u57df\u3001\u7279\u306b\u63a2\u7d22\u7814\u7a76~\u975e\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30c6\u30fc\u30b8\u306b\u30d5\u30a9\u30fc\u30ab\u30b9\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u79fb\u884c\u306e\u30b9\u30c6\u30fc\u30b8\u306b\u304a\u3051\u308b AI\/ML \u6d3b\u7528\u306b\u3064\u3044\u3066\u306f\u5225\u7a3f\u306b\u8b72\u308b\u3053\u3068\u3068\u3057\u307e\u3059\u3002<\/p>\n\n\n\n <\/p>\n\n\n\n \u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u5275\u51fa\u306b\u4f55\u3089\u304b\u306e\u5f62\u3067 AI\/ML \u304c\u7528\u3044\u3089\u308c\u3001\u304b\u3064 2024 \u5e74\u307e\u3067\u306b\u81e8\u5e8a\u8a66\u9a13\uff08Phase I~III\uff09\u304c\u958b\u59cb\u3055\u308c\u3066\u3044\u308b 111 \u306e\u30d7\u30ed\u30c0\u30af\u30c8\u306b\u5bfe\u3059\u308bIQVIA\u793e\u306e\u8abf\u67fb\u306b\u3088\u308b\u3068\u3001AI\/ML \u306b\u3088\u308b\u8ca2\u732e\u306f\u7279\u306b\u5316\u5408\u7269\u8a2d\u8a08\uff08 32 %\uff09\u3084\u6a19\u7684\u540c\u5b9a\uff08 31 %\uff09\u7b49\u306e\u63a2\u7d22\u7814\u7a76\u9818\u57df\u306b\u5bfe\u3059\u308b\u5272\u5408\u304c\u6700\u3082\u9ad8\u304f\u3001\u6b21\u3044\u3067\u30d7\u30ec\u30b7\u30b8\u30e7\u30f3\u30fb\u30e1\u30c7\u30a3\u30b7\u30f3\u958b\u767a\uff08 18 %\uff09\u3084\u81e8\u5e8a\u8a66\u9a13\u306e\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\uff08 13 %\uff09\u7b49\u304c\u6319\u3052\u3089\u308c\u3066\u3044\u307e\u3059<\/a>[5]<\/a><\/sup>\u3002\u307e\u305f\u540c\u30ec\u30dd\u30fc\u30c8\u5185\u3067\u306f\u30012024\u5e74\u306b\u30b0\u30ed\u30fc\u30d0\u30eb\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e R&D \u9818\u57df\u3067\u767a\u751f\u3057\u305f AI\/ML \u95a2\u9023\u306e\u5927\u898f\u6a21\uff08 2 \u5104\u7c73\u30c9\u30eb\u4ee5\u4e0a\uff09\u30c7\u30a3\u30fc\u30eb\u304c 12 \u4ef6\u3042\u308a\u3001\u7dcf\u984d\u7d04 100 \u5104\u7c73\u30c9\u30eb\u306b\u4e0a\u3063\u305f\u3053\u3068\u3082\u793a\u3055\u308c\u3066\u3044\u307e\u3059[5]<\/a><\/sup>\u3002\u3053\u306e\u3088\u3046\u306b AI\/ML \u306f\u3001R&D \u306e\u4e2d\u3067\u3082\u7279\u306b\u4e0a\u6d41\u306e\u5de5\u7a0b\u3067\u3042\u308b\u6a19\u7684\u540c\u5b9a~\u5316\u5408\u7269\u8a2d\u8a08\u7b49\u306e\u63a2\u7d22\u7814\u7a76\u9818\u57df\u306b\u304a\u3051\u308b\u6d3b\u7528\u3084\u6295\u8cc7\u304c\u9032\u3093\u3067\u3044\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n\n\n\n \u5225\u306e\u89b3\u70b9\u3068\u3057\u3066\u30e2\u30c0\u30ea\u30c6\u30a3\u306b\u7740\u76ee\u3092\u3057\u3066\u307f\u308b\u3068\u3001AI\/ML \u306e\u5fdc\u7528\u304c\u76f8\u5bfe\u7684\u306b\u5bb9\u6613\u3068\u8003\u3048\u3089\u308c\u308b\u4f4e\u5206\u5b50\u3060\u3051\u3067\u306f\u306a\u304f\u3001\u8fd1\u5e74\u306f\u6838\u9178\u533b\u85ac\u54c1\u3084\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u30fb\u6297\u4f53\u7b49\u306e\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u306e\u5275\u51fa\u306b\u5bfe\u3059\u308b\u6295\u8cc7\u3082\u9032\u3093\u3067\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Fig.3 \u306b\u793a\u3057\u305f\u5316\u5408\u7269\u63a2\u7d22\u306b\u4fc2\u308b\u6848\u4ef6\u306e\u3046\u3061\u3001Genetic Leap \u793e\u3068 Eli Lilly \u793e\u306e\u63d0\u643a\u306fRNA \u3092\u6a19\u7684\u3068\u3059\u308b\u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u306e\u5275\u51fa\u3092\u76ee\u6307\u3059\u3082\u306e\u3067\u3042\u308a[6]<\/a><\/sup>\u3001Generate:Biomedicines \u793e\u3068Novartis \u793e\u306e\u63d0\u643a\u306f\u8907\u6570\u75be\u60a3\u9818\u57df\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u6cbb\u7642\u85ac\u306e\u5275\u51fa\u3092\u76ee\u6a19\u3068\u3057\u3066\u3044\u307e\u3059[<\/sup><\/a>7]<\/a><\/sup>\u3002<\/p>\n\n\n\n \u3053\u306e\u3088\u3046\u306b\u5275\u85ac\u306b\u4fc2\u308b AI\/ML \u3078\u306e\u6295\u8cc7\u3068\u6d3b\u7528\u306f\u307e\u3059\u307e\u3059\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u5177\u4f53\u7684\u306b\u306f\u3069\u306e\u3088\u3046\u306a\u30b7\u30ca\u30ea\u30aa\u304c\u3042\u308b\u306e\u3067\u3057\u3087\u3046\u304b\u3002\u672c\u7a3f\u3067\u306f\u3054\u304f\u4e00\u90e8\u306b\u9650\u3089\u308c\u307e\u3059\u304c\u3001\u4ee5\u4e0b\u306b\u4f8b\u793a\u3057\u307e\u3059\u3002<\/p>\n\n\n\n \u6cbb\u7642\u6a19\u7684\u540c\u5b9a\u3067\u306f\u3001\u5065\u5e38\u8005\u3068\u60a3\u8005\u306e\u907a\u4f1d\u5b50\uff08\u30b2\u30ce\u30e0\uff09\u3084\u305d\u306e\u767a\u73fe\u72b6\u6cc1\uff08\u30c8\u30e9\u30f3\u30b9\u30af\u30ea\u30d7\u30c8\u30fc\u30e0\u3001\u30d7\u30ed\u30c6\u30aa\u30fc\u30e0\u3001\u30e1\u30bf\u30dc\u30ed\u30fc\u30e0\uff09\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6bd4\u8f03\u3059\u308b\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u4e3b\u6d41\u3067\u3059\u304c\u3001\u3053\u308c\u306b\u3088\u308a\u898b\u3044\u3060\u3055\u308c\u308b\u5019\u88dc\u306f\u81a8\u5927\u304b\u3064\u5fc5\u305a\u3057\u3082\u6a19\u7684\u3068\u3057\u3066\u6709\u52b9\u3067\u306f\u306a\u3044\u3053\u3068\u304c\u8ab2\u984c\u3068\u306a\u3063\u3066\u304a\u308a\u3001\u3053\u308c\u3092\u88dc\u5f37\u30fb\u88dc\u5b8c\u3059\u308b\u3088\u3046\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u3057\u3066\u3001\u75be\u60a3\u3068\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u95a2\u4fc2\u6027\u3092 AI\/ML \u3067\u4e88\u6e2c\u3059\u308b\u3088\u3046\u306a\u624b\u6cd5\u304c\u63d0\u6848\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u3053\u306b\u304a\u3051\u308bAI\/ML\u306e\u7528\u9014\u3082\u69d8\u3005\u8003\u3048\u3089\u308c\u307e\u3059\u304c\u3001\u4f8b\u3068\u3057\u3066\u30bf\u30f3\u30d1\u30af\u8cea\u3092\u30b3\u30fc\u30c9\u3059\u308b\u907a\u4f1d\u5b50\u306b\u6539\u5909\uff08\u30ce\u30c3\u30af\u30c0\u30a6\u30f3\u3084\u904e\u5270\u767a\u73fe\u5316\uff09\u3092\u52a0\u3048\u305f\u969b\u306e\u30c8\u30e9\u30f3\u30b9\u30af\u30ea\u30d7\u30c8\u30fc\u30e0\uff08 mRNA \u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff09\u304b\u3089\u5bfe\u8c61\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u6cbb\u7642\u6a19\u7684\u3068\u3057\u3066\u306e\u6709\u671b\u6027\u3092\u4e88\u6e2c\u3057\u305f\u308a\u3001\u5404\u7a2e\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306b\u84c4\u7a4d\u3055\u308c\u305f\u30bf\u30f3\u30d1\u30af\u8cea\u9593\u306e\u76f8\u4e92\u4f5c\u7528\u3084\u751f\u7269\u5b66\u7684\u6a5f\u80fd\u306b\u4fc2\u308b\u95a2\u4fc2\u6027\u304b\u3089\u5bfe\u8c61\u30bf\u30f3\u30d1\u30af\u8cea\u304c\u6cbb\u7642\u6a19\u7684\u3068\u306a\u308a\u3046\u308b\u75be\u60a3\u3092\u4e88\u6e2c\u3057\u305f\u308a\u3068\u3044\u3063\u305f\u7814\u7a76\u304c\u767a\u8868\u3055\u308c\u3066\u3044\u307e\u3059[8<\/a>, 9<\/a>, 10<\/a><\/sup>]<\/sup><\/a>\u3002<\/p>\n\n\n\n 2024 \u5e74\u306e\u30ce\u30fc\u30d9\u30eb\u5316\u5b66\u8cde\u53d7\u8cde\u3067\u3082\u8a71\u984c\u3068\u306a\u3063\u305f\u3001AI \u306b\u3088\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u7acb\u4f53\u69cb\u9020\u4e88\u6e2c\u3082\u5275\u85ac\u3067\u306e\u6d3b\u7528\u306b\u9ad8\u3044\u671f\u5f85\u304c\u5bc4\u305b\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u6a19\u7684\u3068\u3057\u3066\u306e\u6709\u671b\u6027\u3092\u691c\u8a3c\u3057\u305f\u308a\u5b9f\u969b\u306b\u6a19\u7684\u3068\u3059\u308b\u7d50\u5408\u90e8\u4f4d\u306e\u7279\u5b9a\u306b\u7e4b\u3052\u305f\u308a\u3068\u3044\u3046\u89b3\u70b9\u3067\u306f\u5e83\u7fa9\u306e\u6cbb\u7642\u6a19\u7684\u540c\u5b9a\u306b\u5bc4\u4e0e\u3059\u308b\u6d3b\u7528\u30b7\u30ca\u30ea\u30aa\u3067\u3042\u308a\u3001\u7d50\u5408\u30dd\u30b1\u30c3\u30c8\u7b49\u306e\u69cb\u9020\u3092\u89e3\u660e\u3059\u308b\u3053\u3068\u3067 SBDD\uff08structure based drug discovery\uff09\u30a2\u30d7\u30ed\u30fc\u30c1\u3067\u5f8c\u8ff0\u306e\u5316\u5408\u7269\u63a2\u7d22\u30fb\u8a2d\u8a08\u306b\u5bc4\u4e0e\u3059\u308b\u6d3b\u7528\u30b7\u30ca\u30ea\u30aa\u3067\u3082\u3042\u308a\u307e\u3059[8<\/a><\/sup>]<\/sup><\/a>\u3002<\/p>\n\n\n\n \u5316\u5408\u7269\u63a2\u7d22\u306b\u304a\u3044\u3066\u306f\u3001\u5927\u91cf\u306e\u5316\u5408\u7269\u30e9\u30a4\u30d6\u30e9\u30ea\u30fc\u304b\u3089\u6709\u671b\u306a\u5019\u88dc\u3092\u898b\u3064\u3051\u51fa\u3059\u5f93\u6765\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u578b\u624b\u6cd5\u306b\u4ee3\u308f\u308a\u3001\u76ee\u7684\u3068\u3059\u308b\u85ac\u7406\u7279\u6027\u3092\u6301\u3064\u5316\u5408\u7269\u69cb\u9020\u3092\u76f4\u63a5\u4e88\u6e2c\u3059\u308b\u300c\u9006\u69cb\u9020\u6d3b\u6027\u76f8\u95a2\u89e3\u6790\u300d\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5206\u5b50\u69cb\u9020\u306e\u8868\u73fe\u3068\u3057\u3066\u306f SMILES \u3084 SELFIES\u3001DeepSMILES \u7b49\u306b\u4ee3\u8868\u3055\u308c\u308b\u6587\u5b57\u5217\u8868\u8a18\u3092\u7528\u3044\u3001N-gram\u3084\u3001VAE\u3001GAN\u3001\u518d\u5e30\u7684\u30cb\u30e5\u30fc\u30e9\u30eb\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3001\u5f37\u5316\u5b66\u7fd2\u3001\u81ea\u7136\u8a00\u8a9e\u51e6\u7406\u3067\u6ce8\u76ee\u3092\u96c6\u3081\u3066\u3044\u308b Transformer \u7b49\u306e\u69d8\u3005\u306a\u6280\u8853\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u751f\u6210\u624b\u6cd5\u304c\u63d0\u6848\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u5316\u5408\u7269\u306e\u69cb\u9020\u3092\u6587\u5b57\u5217\u3067\u306f\u306a\u304f\u30b0\u30e9\u30d5\u3068\u3057\u3066\u6349\u3048\u3066\u69cb\u9020\u751f\u6210\u3092\u884c\u3046\u624b\u6cd5\uff08 JT-VAE\u3001Graph-AF \u7b49\uff09\u3084\u3001\u6240\u671b\u306e\u7269\u6027\u3092\u6301\u3064\u5316\u5408\u7269\u306e\u69cb\u9020\u3060\u3051\u3067\u306a\u304f\u305d\u306e\u5408\u6210\u7d4c\u8def\u3082\u63d0\u793a\u3059\u308b\u624b\u6cd5\uff08 casVAE \u7b49\uff09\u3082\u63d0\u6848\u3055\u308c\u3066\u3044\u307e\u3059[8]<\/a><\/sup>\u3002 \u4e0a\u8a18\u4ee5\u5916\u306b\u3082\u3001\u5316\u5408\u7269\u306e\u5206\u5b50\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff08\u5408\u6210\u53ef\u80fd\u6027\u3001\u4f53\u5185\u52d5\u614b\u3001\u6bd2\u6027\u7b49\uff09\u4e88\u6e2c\u3084\u30ea\u30fc\u30c9\u5206\u5b50\u6700\u9069\u5316\u7b49\u3001AI\/ML \u3092\u5275\u85ac\u306e\u63a2\u7d22\u7814\u7a76\u9818\u57df\u3067\u6d3b\u7528\u3059\u308b\u30b7\u30ca\u30ea\u30aa\u306f\u69d8\u3005\u6319\u3052\u3089\u308c\u307e\u3059[4<\/a>, 8<\/a>, 11<\/a><\/sup>]<\/sup><\/a>\u3002<\/p>\n\n\n\n \u5f53\u793e Microsoft \u306b\u304a\u3044\u3066\u3082\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u5275\u85ac\u306b\u7279\u5316\u3057\u305f AI \u30e2\u30c7\u30eb\u306e\u958b\u767a\u3084\u3001Azure OpenAI \u3084Microsoft 365 Copilot \u7b49\u306eAI\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6d3b\u7528\u306b\u3088\u308b\u63a2\u7d22\u7814\u7a76\u30d7\u30ed\u30bb\u30b9\u306e\u751f\u7523\u6027\u5411\u4e0a\u7b49\u306e\u5b9f\u4f8b\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n\n\n\n BioEmu\uff08Biomolecular Emulator\uff09\u306f Microsoft Research \u304c\u958b\u767a\u3057\u305f\u30c7\u30a3\u30fc\u30d7\u30e9\u30fc\u30cb\u30f3\u30b0\u30e2\u30c7\u30eb\u3067\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u304c\u3068\u308a\u3046\u308b\u81a8\u5927\u306a\u69cb\u9020\u306e\u30a2\u30f3\u30b5\u30f3\u30d6\u30eb\u3092\u751f\u6210\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u5bfe\u8c61\u30bf\u30f3\u30d1\u30af\u8cea\u304c\u751f\u4f53\u30fb\u6eb6\u6db2\u4e2d\u3067\u53d6\u308a\u3046\u308b\u69cb\u9020\u306e\u30d0\u30ea\u30a8\u30fc\u30b7\u30e7\u30f3\u3092\u7406\u89e3\u3059\u308b\u3053\u3068\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002<\/p>\n\n\n\n \u5f93\u6765\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u751f\u4f53\u30fb\u6eb6\u6db2\u4e2d\u3067\u306e\u69cb\u9020\u3092\u4e88\u6e2c\u3059\u308b\u65b9\u6cd5\u3068\u3057\u3066\u306f\u4e3b\u306b\u5206\u5b50\u52d5\u529b\u5b66\uff08MD\uff09\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u304c\u7528\u3044\u3089\u308c\u3066\u304d\u307e\u3057\u305f\u304c\u3001\u3053\u306e\u624b\u6cd5\u3067\u793a\u5506\u3092\u5f97\u308b\u306b\u306f\u975e\u5e38\u306b\u9577\u6642\u9593\u306e\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3068\u81a8\u5927\u306a\u91cf\u306e\u8a08\u7b97\u51e6\u7406\u304c\u5fc5\u8981\u3067\u3042\u308a\u3001\u6642\u3068\u3057\u3066\u305d\u308c\u306f\u5b9f\u73fe\u53ef\u80fd\u306a\u7bc4\u56f2\u3092\u8d85\u3048\u3066\u3057\u307e\u3046\u3068\u3044\u3046\u8ab2\u984c\u304c\u3042\u308a\u307e\u3059\u3002\u4e00\u65b9 BioEmu \u306f\u3001MD \u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u6bd4\u3079\u3066\u8a08\u7b97\u52b9\u7387\u304c\u6841\u9055\u3044\u306b\u9ad8\u304f\u30011\u3064\u306e GPU \u30671\u6642\u9593\u5f53\u305f\u308a\u6570\u5343\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u69cb\u9020\u3092\u751f\u6210\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059[12]<\/a><\/sup>\u3002\u3053\u3053\u3067\u3001BioEmu \u306e\u6709\u7528\u6027\u3092\u793a\u5506\u3059\u308b\u7814\u7a76\u6210\u679c\u306e\u4f8b\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n\n\n\n \u307e\u305a\u306f\u3001BioEmu \u306b\u3088\u308a\u672a\u77e5\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u914d\u5217\u306e\u69cb\u9020\u3092\u4e88\u6e2c\u3057\u305f\u4f8b\u3067\u3059\u3002\u6b21\u306e Fig. \u306f\u3001\u30b3\u30ec\u30e9\u306e\u539f\u56e0\u83cc Vibrio cholerae<\/em> \u7531\u6765\u306e\u30bf\u30f3\u30d1\u30af\u8ceaLapD\u306b\u3064\u3044\u3066\u3001BioEmu \u304c\u4e88\u6e2c\u3057\u305f\u69cb\u9020\u3068\u5b9f\u9a13\u3067\u5f97\u3089\u308c\u305f\u69cb\u9020\u3092\u91cd\u306d\u5408\u308f\u305b\u3066\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u5bfe\u8c61\u3068\u3057\u305fLapD\u306e\u69cb\u9020\u306f\u5b9f\u9a13\u7684\u306b\u77e5\u3089\u308c\u3066\u3044\u308b\u3082\u306e\u306e BioEmu \u306e\u5b66\u7fd2\u30c7\u30fc\u30bf\u306b\u306f\u542b\u307e\u308c\u3066\u3044\u306a\u304b\u3063\u305f\u305f\u3081\u3001BioEmu-1 \u304c\u305d\u306e\u69cb\u9020\u306e\u300c\u4e88\u6e2c\u300d\u306b\u6210\u529f\u3057\u3066\u3044\u308b\u3053\u3068\u304c\u4f3a\u3048\u307e\u3059\u3002\u307e\u305f\u3001BioEmu \u306f\u5b9f\u9a13\u7684\u306b\u307e\u3060\u5f97\u3089\u308c\u3066\u3044\u306a\u3044\u4e2d\u9593\u7684\u306a\u69cb\u9020\u3082\u4e88\u6e2c\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u5bfe\u8c61\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u751f\u5316\u5b66\u7684\u306a\u3075\u308b\u307e\u3044\u306b\u5bfe\u3059\u308b\u4eee\u8aac\u3065\u304f\u308a\u306b\u8ca2\u732e\u3057\u3046\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n\n\n\n \u3053\u308c\u306b\u52a0\u3048\u3066\u3001BioEmu \u304c\u3054\u304f\u50c5\u304b\u306a\u8a08\u7b97\u30b3\u30b9\u30c8\u3067 MD \u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u7d50\u679c\u3092\u6b63\u78ba\u306b\u518d\u73fe\u3067\u304d\u308b\uff08GPU \u4f7f\u7528\u6642\u9593\u304c MD \u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306e 1 \u4e07~10 \u4e07\u5206\u306e 1 \uff09\u3053\u3068\u3084\u3001\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u5b89\u5b9a\u6027\uff08\u30d5\u30a9\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u306e\u81ea\u7531\u30a8\u30cd\u30eb\u30ae\u30fc\u0394G<\/em> \uff09\u3082\u9ad8\u3044\u7cbe\u5ea6\u3067\u4e88\u6e2c\u3057\u3046\u308b\u3053\u3068\u7b49\u304c\u7814\u7a76\u6210\u679c\u3068\u3057\u3066\u30d7\u30ec\u30d7\u30ea\u30f3\u30c8\u3067\u516c\u8868\u3055\u308c\u3066\u3044\u307e\u3059[12<\/a>, 13<\/a><\/sup>]<\/sup><\/a>\u3002\u306a\u304a\u3001BioEmu \u306f\u73fe\u5728\u3001Azure AI Foundry \u306e\u30e2\u30c7\u30eb\u30ab\u30bf\u30ed\u30b0\u3067\u9078\u629e\u3057\u3066\u30c7\u30d7\u30ed\u30a4\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u3067\u3059\u3002<\/p>\n\n\n\n TamGen\uff08Target-aware molecule Generation\uff09\u306f\u3001Global Health Drug Discovery Institute\u3068Microsoft Research\u306e\u5171\u540c\u7814\u7a76\u3092\u7d4c\u3066\u958b\u767a\u3055\u308c\u305fTransformer\u30d9\u30fc\u30b9\u306e\u751f\u6210AI\u30e2\u30c7\u30eb\uff08Chemical Language Model\uff09\u3067\u3001SMILES\uff08Simplified Molecular Input Line Entry System\uff09\u8868\u8a18\u6cd5\u306b\u5909\u63db\u3057\u305f\u5206\u5b50\u60c5\u5831\u3092\u51e6\u7406\u3057\u3001\u6a19\u7684\u30bf\u30f3\u30d1\u30af\u8cea\u7279\u7570\u7684\u306a\u5019\u88dc\u5316\u5408\u7269\u306e\u69cb\u9020\u3092\u751f\u6210\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059[<\/sup><\/a>14<\/a><\/sup>]<\/sup><\/a>\u3002<\/p>\n\n\n\n \u5f93\u6765\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\uff08in vitro<\/em>\u306e\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3001in silico<\/em>\u306e\u30d0\u30fc\u30c1\u30e3\u30eb\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u7b49\uff09\u306b\u3088\u3063\u3066\u30d2\u30c3\u30c8\u5316\u5408\u7269\u3092\u898b\u51fa\u3059\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u901a\u5e38104<\/sup>~108<\/sup>\u7a0b\u5ea6\u306e\u5316\u5408\u7269\u30e9\u30a4\u30d6\u30e9\u30ea\u30fc\u3092\u63a2\u7d22\u3057\u307e\u3059\u304c\u3001\u751f\u6210AI\u30e2\u30c7\u30eb\u3092\u6d3b\u7528\u3059\u308b\u30a2\u30d7\u30ed\u30fc\u30c1\uff08Generative drug design\uff09\u3067\u306f1060<\/sup>\u4ee5\u4e0a\u3068\u3082\u3044\u308f\u308c\u308b\u5e83\u5927\u306a\u30b1\u30df\u30ab\u30eb\u30b9\u30da\u30fc\u30b9\u3092\u63a2\u7d22\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u307e\u3059[15<\/a><\/sup>]<\/sup><\/a>\u3002Generative drug design\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u95a2\u3057\u3066\u306f\u3053\u308c\u307e\u3067\u3082\u3001\u81ea\u5df1\u56de\u5e30\uff08AR\uff09\u30e2\u30c7\u30eb\u3084GAN\u3001VAE\u3001\u62e1\u6563\u30e2\u30c7\u30eb\u7b49\u306e\u69d8\u3005\u306aAI\u6280\u8853\u306b\u57fa\u3065\u304f\u624b\u6cd5\u304c\u63d0\u6848\u3055\u308c\u3066\u3044\u307e\u3059\u304c\u3001\u751f\u5316\u5b66\u7684\u30a2\u30c3\u30bb\u30a4\u306b\u3088\u308b\u691c\u8a3c\u304c\u4e0d\u8db3\u3057\u3066\u3044\u305f\u308a\u3001\u5408\u6210\u53ef\u80fd\u6027\u3092\u542b\u3080Drug-likeness\u304c\u4e0d\u5341\u5206\u3067\u3042\u3063\u305f\u308a\u3068\u3044\u3063\u305f\u7406\u7531\u3067\u5275\u85ac\u3067\u306e\u5b9f\u7528\u6027\u304c\u4e4f\u3057\u3044\u30b1\u30fc\u30b9\u3082\u591a\u304f\u307f\u3089\u308c\u307e\u3057\u305f[<\/sup><\/a>15<\/a><\/sup>]<\/sup><\/a>\u3002\u4e00\u65b9TamGen\u306f\u3001\u8fd1\u5e74\u63d0\u6848\u3055\u308c\u305f5\u3064\u306eGenerative drug design\u624b\u6cd5\uff08LiGAN\u30013D-AR\u3001Pocket2Mol\u3001ResGen\u3001 TargetDiff\uff09\u306b\u6bd4\u3057\u3066\u3001\u6a19\u7684\u30bf\u30f3\u30d1\u30af\u8cea\u3078\u306e\u7d50\u5408\u6027\u3060\u3051\u3067\u306a\u304f\u3001\u5b9f\u969b\u306b\u85ac\u5264\u5316\u3067\u304d\u308b\u304b\u3069\u3046\u304b\uff08Drug-likeness\uff09\u306b\u4fc2\u308b\u6307\u6a19\u306b\u304a\u3044\u3066\u3082\u3088\u3044\u6210\u7e3e\u3092\u53ce\u3081\u3066\u3044\u307e\u3059[<\/sup><\/a>15<\/a><\/sup>]<\/sup><\/a>\u3002\u3088\u308a\u5177\u4f53\u7684\u306b\u306f\u3001\u6a19\u7684\u30bf\u30f3\u30d1\u30af\u8cea\u3078\u306e\u7d50\u5408\u6027\u306e\u6307\u6a19\u3068\u3057\u3066\u30c9\u30c3\u30ad\u30f3\u30b0\u30b9\u30b3\u30a2\u3092\u3001Drug-likeness\u306e\u6307\u6a19\u3068\u3057\u3066Quantitative Estimate of Drug-likeness (QED)\u3084\u3001\u533b\u85ac\u54c1\u306b\u306a\u308a\u3084\u3059\u3044\u5316\u5408\u7269\u306e\u7279\u6027\u3092\u8868\u3059\u7d4c\u9a13\u5247Lipinski\u2019s Rule of Five\u3001\u5408\u6210\u96e3\u6613\u5ea6\u3092\u8868\u3059synthetic accessibility scores (SAS)\u3001\u305d\u3057\u3066\u8102\u6eb6\u6027\u3092\u8868\u3059LogP\u7b49\u3067\u30d9\u30f3\u30c1\u30de\u30fc\u30af\u8a55\u4fa1\u3057\u305f\u3068\u3053\u308d\u3001TamGen\u306f\u7dcf\u5408\u7684\u306b\u6700\u4e0a\u4f4d\u306b\u30e9\u30f3\u30af\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n\n\n\n \u307e\u305f\u3001\u7d50\u6838\u83cc\u7531\u6765\u306e\u30bf\u30f3\u30d1\u30af\u8ceaClpP\u30d7\u30ed\u30c6\u30a2\u30fc\u30bc\u3092\u6a19\u7684\u3068\u3057\u3066\u3001TamGen\u306b\u3088\u308b\u5019\u88dc\u5316\u5408\u7269\u306e\u751f\u6210\u3068\u6539\u826f\u8a2d\u8a08\u3001\u5b9f\u9a13\u306b\u3088\u308b\u6d3b\u6027\u78ba\u8a8d\u306e\u7d44\u307f\u5408\u308f\u305b\u306b\u3088\u308b\u7814\u7a76\u306e\u7d50\u679c\u3068\u3057\u3066\u3001IC\u2085\u2080\u304c40 \u03bcM\u672a\u6e80\u306e\u9ad8\u3044\u963b\u5bb3\u6d3b\u6027\u3092\u793a\u3059\u5316\u5408\u7269\u304c14\u7a2e\u985e\u3001\u305d\u306e\u3046\u3061\u6700\u3082\u9ad8\u3044\u6d3b\u6027\u3068\u3057\u3066IC\u2085\u2080\u304c1.88 \u03bcM\u306e\u30d2\u30c3\u30c8\u5316\u5408\u7269\u304c\u5f97\u3089\u308c\u3066\u304a\u308a[<\/sup><\/a>15<\/a><\/sup>]<\/sup><\/a>\u3001\u5275\u85ac\u306b\u304a\u3051\u308bTamGen\u306e\u5b9f\u7528\u6027\u304c\u793a\u5506\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u306a\u304a\u3001TamGen\u306f\u73fe\u5728\u3001Azure AI Foundry\u306e\u30e2\u30c7\u30eb\u30ab\u30bf\u30ed\u30b0\u3067\u9078\u629e\u3057\u3066\u30c7\u30d7\u30ed\u30a4\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u3067\u3059\u3002<\/p>\n\n\n\n \u4e0a\u8a18\u306e\u3088\u3046\u306b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u5275\u85ac\u306b\u7279\u5316\u3057\u305fAI\u30e2\u30c7\u30eb\u306e\u63d0\u4f9b\u3060\u3051\u3067\u306a\u304f\u3001Azure OpenAI \u3084Microsoft 365 Copilot \u306e\u30a8\u30fc\u30b8\u30a7\u30f3\u30c8\u7b49\u3092\u7d44\u307f\u5408\u308f\u305b\u3001\u63a2\u7d22\u7814\u7a76\u30d7\u30ed\u30bb\u30b9\u306e\u751f\u7523\u6027\u3092\u5287\u7684\u306b\u9ad8\u3081\u308b\u3088\u3046\u306a\u6d3b\u7528\u30b7\u30ca\u30ea\u30aa\u3082\u591a\u6570\u5b58\u5728\u3057\u307e\u3059\u3002<\/p>\n\n\n\n \u4f8b\u3048\u3070\u3001Amgen \u793e\u3067\u306f\u5168\u793e\u7684\u306b Microsoft 365 Copilot \u3092\u6d3b\u7528\u3044\u305f\u3060\u3044\u3066\u3044\u307e\u3059\u304c\u3001\u7279\u306b R&D \u90e8\u9580\u306e\u7814\u7a76\u8005\u5411\u3051\u306b\u306f Catalyst Copilot \u3068\u547c\u3070\u308c\u308b\u30a8\u30fc\u30b8\u30a7\u30f3\u30c8\u3092\u72ec\u81ea\u306b\u69cb\u7bc9\u3057\u3001\u6cbb\u7642\u9818\u57df\u5225\u306b\u6574\u7406\u3055\u308c\u305f\u30ca\u30ec\u30c3\u30b8\u3084\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0 \u30d3\u30c7\u30aa\u3001\u88fd\u54c1\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306a\u3069\u304c\u542b\u307e\u308c\u308b\u81a8\u5927\u306a\u60c5\u5831\u306b\u5bfe\u3057\u3001\u81ea\u7136\u8a00\u8a9e\u306e\u30af\u30a8\u30ea\u3067\u5373\u5ea7\u306b\u30a2\u30af\u30bb\u30b9\u3067\u304d\u308b\u74b0\u5883\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059[16<\/a>]<\/sup>\u3002<\/p>\n\n\n\n \u307e\u305f\u3001Boehringer Ingelheim \u793e\u3067\u306f\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u81e8\u5e8a\u7814\u7a76\u30fb\u7279\u8a31\u7b49\u306e\u7279\u6b8a\u306a\u60c5\u5831\u3082\u542b\u3080\u30c7\u30fc\u30bf\u306e\u91cf\u306e\u81a8\u5927\u3055\u3068\u3001\u305d\u306e\u4e2d\u3067\u306e\u30b3\u30f3\u30c6\u30ad\u30b9\u30c8\uff08\u4f8b\uff1a\u7279\u6b8a\u306a\u533b\u7642\u7528\u8a9e\u3084\u7565\u8a9e\u3001\u8868\u73fe\u306e\u63fa\u308c\uff09\u306e\u8907\u96d1\u3055\u304c\u30cd\u30c3\u30af\u3067\u30ca\u30ec\u30c3\u30b8\u6d3b\u7528\u306b\u81a8\u5927\u306a\u6642\u9593\u3092\u8981\u3057\u3066\u3044\u305f\u8ab2\u984c\u306b\u5bfe\u3057\u3001Azure OpenAI \u3092\u6d3b\u7528\u3057\u305f\u30ca\u30ec\u30c3\u30b8\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0 iQNow \u3092\u958b\u767a\u3057\u3001\u30b0\u30eb\u30fc\u30d7\u5168\u4f53\u3067\u7d04 150,000 \u6642\u9593\u306e\u52b4\u50cd\u6642\u9593\u3092\u524a\u6e1b\u3057\u3066\u3044\u307e\u3059[17]<\/a><\/sup>\u3002\u3053\u3053\u3067\u306f\u3054\u304f\u4e00\u90e8\u306e\u4f8b\u3092\u6319\u3052\u307e\u3057\u305f\u304c\u3001\u65e5\u672c\u56fd\u5185\u3092\u542b\u3080\u30b0\u30ed\u30fc\u30d0\u30eb\u306e\u69d8\u3005\u306a\u88fd\u85ac\u4f01\u696d\u306b\u304a\u3044\u3066\u3001\u4e3b\u306b\u30ca\u30ec\u30c3\u30b8\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u3057\u3066\u3053\u3046\u3057\u305f AI\/ML \u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u6d3b\u7528\u3059\u308b\u3053\u3068\u3067\u63a2\u7d22\u7814\u7a76\u30d7\u30ed\u30bb\u30b9\u306e\u751f\u7523\u6027\u5411\u4e0a\u3092\u76ee\u6307\u3059\u8a66\u307f\u304c\u9032\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n \u3053\u3053\u307e\u3067\u306b\u8ff0\u3079\u305f\u3088\u3046\u306b\u3001\u5275\u85ac\u3067\u306eAI\/ML\u6d3b\u7528\u306f\u5e02\u5834\u306e\u671f\u5f85\u3068\u73fe\u5834\u306e\u7814\u7a76\u30fb\u5fdc\u7528\u304c\u307e\u3059\u307e\u3059\u62e1\u5927\u3057\u3066\u304a\u308a\u3001\u65b0\u85ac\u5275\u51fa\u306e\u751f\u7523\u6027\u3092\u5287\u7684\u306b\u9ad8\u3081\u308b\u53ef\u80fd\u6027\u3092\u793a\u3057\u3064\u3064\u3042\u308a\u307e\u3059\u3002\u4e00\u65b9\u3067\u3001in silico<\/em>\u3068in vitro<\/em>\u306e\u9069\u6750\u9069\u6240\u3067\u306e\u4f7f\u3044\u5206\u3051\u306f\u3001\u3082\u3061\u308d\u3093\u5f53\u9762\u5fc5\u8981\u3067\u3042\u308a\u7d9a\u3051\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002\u307e\u305f\u3001AI\/ML\u306b\u3088\u3063\u3066\u4e88\u6e2c\u30fb\u751f\u6210\u3055\u308c\u305f\u5316\u5408\u7269\u304c\u73fe\u5b9f\u306b\u5408\u6210\u30fb\u5165\u624b\u3067\u304d\u306a\u3044\u3068\u3044\u3063\u305fin silico<\/em>\u3068in vitro\u306e\u5883\u754c\u3067\u8d77\u3053\u308b\u554f\u984c\u306e\u89e3\u6c7a\u3084\u3001\u8a3a\u7642\u60c5\u5831\u7b49\u306e\u30d2\u30c8\u30c7\u30fc\u30bf\u3068\u5206\u5b50\u30c7\u30fc\u30bf\u306e\u7d71\u5408\u7684\u306a\u89e3\u6790\u3001\u69cb\u9020\u3084\u7269\u6027\u304c\u3088\u308a\u8907\u96d1\u306a\u30da\u30d7\u30c1\u30c9\u30fb\u6297\u4f53\u30fb\u6838\u9178\u7b49\u65b0\u898f\u30e2\u30c0\u30ea\u30c6\u30a3\u5206\u5b50\u3067\u306e\u6d3b\u7528\u7b49\u3001\u53d6\u308a\u7d44\u3080\u3079\u304d\u8ab2\u984c\u306f\u591a\u304f\u6b8b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/em><\/p>\n\n\n\n \u3053\u3046\u3057\u305f\u8ab2\u984c\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u304a\u3051\u308b\u6280\u8853\u7684\u5074\u9762\u306b\u304a\u3044\u3066\u306f\u3001<\/em>\u65b0\u898f\u30e2\u30c7\u30eb\u306e\u958b\u767a\u3084\u6539\u826f\u3001\u69d8\u3005\u306a\u30e2\u30c7\u30eb\u3084\u624b\u6cd5\u306e\u7d44\u307f\u5408\u308f\u305b\u306b\u3088\u308bAI\/ML\u81ea\u4f53\u306e\u6280\u8853\u9032\u5316\u306f\u5f53\u7136\u306a\u304c\u3089\u3001\u305d\u308c\u3089\u3092\u30af\u30e9\u30a6\u30c9\u4e0a\u3067\u884c\u3046\u3053\u3068\u3067\u30d5\u30ec\u30ad\u30b7\u30d3\u30ea\u30c6\u30a3\u3084\u30a2\u30b8\u30ea\u30c6\u30a3\u3092\u9ad8\u3081\u305f\u308a\u3001HPC\uff08High Performance Computing\uff09\u3084\u5c06\u6765\u7684\u306b\u306f\u91cf\u5b50\u30b3\u30f3\u30d4\u30e5\u30fc\u30c6\u30a3\u30f3\u30b0\u7b49\u306e\u4ed6\u306e\u6280\u8853\u3068\u9023\u643a\u3055\u305b\u305f\u308a\u3068\u3044\u3063\u305f\u3053\u3068\u304c\u307e\u3059\u307e\u3059\u91cd\u8981\u306b\u306a\u3063\u3066\u3044\u304f\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n\n\n\n [1] \u88fd\u85ac\u5354, \u30c7\u30fc\u30bf\u3067\u898b\u308b\u533b\u85ac\u54c1\u7814\u7a76\u958b\u767a\u306e\u5b9f\u614b, \u88fd\u85ac\u5354\u30cb\u30e5\u30fc\u30ba\u30ec\u30bf\u30fc, 2024\u5e741\u6708\u53f7 No.224.<\/a><\/p>\n\n\n\n <\/a>[2] AI\u2019s potential to accelerate drug discovery needs a reality check. Nature<\/em> 622<\/strong>, 217 (2023)<\/a>.<\/p>\n\n\n\n <\/a>[3] McKinsey & Company. Generative AI in the pharmaceutical industry: Moving from hype to reality, January 2024.<\/a><\/p>\n\n\n\n <\/a><\/a>[4] Zhang, K., Yang, X., Wang, Y. et al.<\/em>, Artificial intelligence in drug development, Nat Med<\/em> 31<\/strong>, 45\u201359 (2025).<\/a><\/p>\n\n\n\n [5] IQVIA, Global Trends in R&D 2025. Institute Report, Mar 26, 2025<\/a>.<\/p>\n\n\n\n [6] Reuters, Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs, September 2024<\/a>.<\/p>\n\n\n\n [7] Generate:Biomedicines, Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI, September 2024.<\/a><\/p>\n\n\n\n <\/a>[8] \u56fd\u7acb\u7814\u7a76\u958b\u767a\u6cd5\u4eba \u79d1\u5b66\u6280\u8853\u632f\u8208\u6a5f\u69cb\uff08JST\uff09\u7814\u7a76\u958b\u767a\u6226\u7565\u30bb\u30f3\u30bf\u30fc\uff08CRDS\uff09, \u7814\u7a76\u958b\u767a\u306e\u4fef\u77b0\u5831\u544a\u66f8\u3000\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u81e8\u5e8a\u533b\u5b66\u5206\u91ce, 2024\u5e74<\/a>.<\/p>\n\n\n\n <\/a>[9] Namba, S., et al.<\/em>, From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signature, Bioinformatics<\/em> 38<\/strong>, Issue Supplement_1, (2022), Pages i68\u2013i76<\/a>.<\/p>\n\n\n\n <\/a>[10] Han, Y., et al.<\/em>, Empowering the discovery of novel target-disease associations via machine learning approaches in the open targets platform, BMC Bioinformatics<\/em> 23 <\/strong>232 (2022)<\/a>.<\/p>\n\n\n\n <\/a>[11] \u7530\u4e2d\u6210\u5178, \u5e83\u5ddd\u8cb4\u6b21, \u6c60\u53e3\u6e80\u5fb3, \u30a4\u30f3\u30b7\u30ea\u30b3\u5275\u85ac \u8a08\u7b97\u5275\u85ac\u306e\u57fa\u790e\u304b\u3089\u5b9f\u4f8b\u307e\u3067, \u68ee\u5317\u51fa\u7248, 2025<\/a><\/p>\n\n\n\n <\/a>[12] Microsoft Research Blog, Exploring the structural changes driving protein function with BioEmu-1, February 2025<\/a>.<\/p>\n\n\n\n <\/a>[13] Lewis, S., et al.<\/em>, Scalable emulation of protein equilibrium ensembles with generative deep learning, bioRxiv 2024.12.05.626885<\/a>.<\/p>\n\n\n\n <\/a>[14] Microsoft Research Blog, Accelerating drug discovery with TamGen: A generative AI approach to target-aware molecule generation, November 2024<\/a>.<\/p>\n\n\n\n <\/a>[15] Wu, K., Xia, Y., Deng, P. et al.<\/em>, TamGen: drug design with target-aware molecule generation through a chemical language model, Nat Commun<\/em> 15<\/strong>, 9360 (2024).<\/a><\/p>\n\n\n\n <\/a>[16] Microsoft Windows Blog for Japan, \u5909\u9769\u306e\u63a8\u9032\u8005, 2025\u5e743\u6708<\/a>.<\/p>\n\n\n\n

\u2161. \u5275\u85ac\u306b\u304a\u3051\u308bAI\/ML\u306e\u5e02\u5834\u52d5\u5411\u3068\u4e3b\u306a\u6d3b\u7528\u30b7\u30ca\u30ea\u30aa<\/h3>\n\n\n\n

1\uff09\u6a19\u7684\u540c\u5b9a:<\/h5>\n\n\n\n
2\uff09\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u7acb\u4f53\u69cb\u9020\u4e88\u6e2c:<\/h5>\n\n\n\n
3\uff09\u5316\u5408\u7269\u63a2\u7d22:<\/h5>\n\n\n\n
<\/p>\n\n\n\n\u2162. Microsoft\u306e\u53d6\u308a\u7d44\u307f\u3084\u95a2\u9023\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3<\/h1>\n\n\n\n
1) BioEmu\uff08Azure AI Foundry\u3067\u5229\u7528\u53ef\uff09\u306b\u3088\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u69cb\u9020\u306e\u4e88\u6e2c<\/h5>\n\n\n\n


2) TamGen\uff08Azure AI Foundry\u3067\u5229\u7528\u53ef\uff09\u306b\u3088\u308b\u5316\u5408\u7269\u69cb\u9020\u306e\u751f\u6210<\/h5>\n\n\n\n


3) Azure OpenAI \u3084 Microsoft 365 Copilot \u7b49\u306b\u3088\u308b\u63a2\u7d22\u7814\u7a76\u30d7\u30ed\u30bb\u30b9\u306e\u751f\u7523\u6027\u5411\u4e0a<\/h5>\n\n\n\n
\u2163. \u5275\u85ac\u306b\u304a\u3051\u308bAI\/ML\u306e\u6d3b\u7528\u306b\u4fc2\u308b\u8ab2\u984c\u3068\u5c55\u671b<\/h3>\n\n\n\n
\u53c2\u8003\u6587\u732e<\/h3>\n\n\n\n